Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial

@article{Rossouw2002RisksAB,
  title={Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial},
  author={J. Rossouw and G. Anderson and R. Prentice and A. LaCroix and C. Kooperberg and M. Stefanick and R. Jackson and S. Beresford and B. Howard and Karen C Johnson and J. Kotchen and J. Ockene},
  journal={Obstetrics \& Gynecology},
  year={2002},
  volume={101},
  pages={194}
}
CONTEXT Despite decades of accumulated observational evidence, the balance of risks and benefits for hormone use in healthy postmenopausal women remains uncertain. OBJECTIVE To assess the major health benefits and risks of the most commonly used combined hormone preparation in the United States. DESIGN Estrogen plus progestin component of the Women's Health Initiative, a randomized controlled primary prevention trial (planned duration, 8.5 years) in which 16608 postmenopausal women aged 50… Expand

Paper Mentions

Interventional Clinical Trial
This pilot study examines the effect of stabilizing ovarian hormones on eating behaviors and brain activation in women with binge eating (n=15) using functional magnetic resonance… Expand
ConditionsBinge Eating, Binge-Eating Disorder, Bulimia Nervosa, (+1 more)
InterventionDrug
Interventional Clinical Trial
The proposed study involves experimentally manipulating reproductive hormones in nonpregnant, euthymic women to create a scaled down version of the changes that occur during pregnancy… Expand
ConditionsDepression, Depression, Postpartum, Perinatal Depression, (+1 more)
InterventionDrug
Interventional Clinical Trial
Menopause is defined as the last episode of menstrual bleeding, resulting from the interruption of ovarian function by follicular depletion. It is characterized by the presence of… Expand
ConditionsHormone Replacement Therapy, Menopause
InterventionDrug
Interventional Clinical Trial
This 12-week study is a randomized, placebo-controlled study assessing the efficacy of an herbal blend on menopausal symptoms and quality of life.  
ConditionsMenopause
InterventionDietary Supplement, Other
Estrogen plus progestin, benefits and risks: the "Women's Health Initiative" trials.
  • K. Keller, L. Lemberg
  • Medicine
  • American journal of critical care : an official publication, American Association of Critical-Care Nurses
  • 2005
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
Postmenopausal hormone treatment.
Estrogen plus progestin and the risk of coronary heart disease.
Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 65 REFERENCES
Postmenopausal Hormone Therapy and Risk of Stroke: The Heart and Estrogen-progestin Replacement Study (HERS)
Effect of Oral Postmenopausal Hormone Replacement on Progression of Atherosclerosis: A Randomized, Controlled Trial
...
1
2
3
4
5
...